RhumbLine Advisers’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$520K Buy
117,678
+16,141
+16% +$95.5K ﹤0.01% 2587
2025
Q4
$543K Sell
101,537
-750
-0.7% -$5.96K ﹤0.01% 2616
2025
Q3
$984K Buy
102,287
+23,293
+29% +$215K ﹤0.01% 2252
2025
Q2
$581K Buy
78,994
+13,668
+21% +$91.7K ﹤0.01% 2594
2025
Q1
$306K Buy
65,326
+4,963
+8% +$24.8K ﹤0.01% 2876
2024
Q4
$273K Buy
60,363
+24,664
+69% +$131K ﹤0.01% 3045
2024
Q3
$99.2K Sell
35,699
-2,357
-6% -$6.26K ﹤0.01% 3497
2024
Q2
$116K Buy
+38,056
New +$147K ﹤0.01% 3471

Other funds holding ASPI

RhumbLine Advisers's ASPI Position: Q1 2026 in Review

RhumbLine Advisers increased its ASP Isotopes (ASPI) stake by 16% in Q1 2026, buying an estimated $95.5K and bringing the position to 117,678 shares worth $520K. The position accounts for ﹤0.01% of the portfolio, ranked #2587.

RhumbLine Advisers first reported a position in ASPI in Q2 2024 and has held it in 8 quarters since. The position peaked at $984K in Q3 2025. 177 funds tracked by Wall St. Rank hold ASPI as of Q1 2026.

  • RhumbLine Advisers held 117,678 shares of ASP Isotopes worth $520K as of Q1 2026.
  • RhumbLine Advisers bought 16,141 ASP Isotopes shares in Q1 2026, an estimated $95.5K.
  • ASP Isotopes made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #2587 holding.
  • RhumbLine Advisers first reported a position in ASP Isotopes in Q2 2024 and has held it in 8 quarters since.
  • RhumbLine Advisers's ASP Isotopes position peaked at $984K in Q3 2025.
  • 177 funds tracked by Wall St. Rank held ASP Isotopes as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.